Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Dexchlorpheniramine maleate
Drug ID BADD_D00627
Description Dexchlorpheniramine is the S-enantiomer of chlorpheniramine which is a 1st generation anti-histamine. Dexchlorpheniramine has more pharmacological activity than the R and so is more potent than the racemic mixture.
Indications and Usage Dexchlorpheniramine can be used in the treatment of perennial and seasonal allergic rhinitis, vasomotor rhiniti, allergic conjunctivitis due to inhalant allergens and foods, mild uncomplicated allergic skin manifestations of urticaria and angioedema, amelioration of allergic reactions to blood or plasma, and dermographism.
Marketing Status Prescription; Discontinued
ATC Code R06AB02
DrugBank ID DB09555
KEGG ID D00668
MeSH ID C018904
PubChem ID 5281070
TTD Drug ID D05ZGQ
NDC Product Code 61281-3400; 15370-150; 49452-2467; 63943-4683; 12294-0010; 64543-600
Synonyms dexchlorpheniramine | dexclorfeniramine | dexchlorpheniramine, (+-)-isomer | dexchlorpheniramine, (R)-isomer | dexchlorpheniramine, monohydrochloride, (S)-isomer | Dexclor | Polaramine | Polaramin | dexchlorpheniramine monohydrochloride | Polaronil | dexchlorpheniramine maleate | dextrochlorpheniramine maleate | dexchlorpheniramine maleate (1:1), (+-)-isomer | dexchlorpheniramine maleate (1:1), (R)-isomer | dexchlorpheniramine maleate (1:1), (S)-isomer | dexchlorpheniramine sodium maleate (1:1) | Polargen TD
Chemical Information
Molecular Formula C20H23ClN2O4
CAS Registry Number 2438-32-6
SMILES CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Paraesthesia17.02.06.005--
Photosensitivity reaction23.03.09.003--
Pollakiuria20.02.02.007--
Restlessness19.11.02.002; 17.02.05.021--
Sedation17.02.04.005--Not Available
Seizure17.12.03.001--
Somnolence19.02.05.003; 17.02.04.006--
Thrombocytopenia01.08.01.002--Not Available
Tinnitus17.04.07.004; 04.04.01.002--
Tremor17.01.06.002--
Urinary retention20.02.02.011--
Urticaria23.04.02.001; 10.01.06.001--
Vertigo17.02.12.002; 04.04.01.003--
Vision blurred06.02.06.007; 17.17.01.010--
Vomiting07.01.07.003--
Wheezing22.03.01.009--
Decreased appetite14.03.01.005; 08.01.09.028--
Increased bronchial secretion22.02.04.007--Not Available
The 2th Page    First    Pre   2    Total 2 Pages